What is Narcolepsy Drug Market Scope?
Narcolepsy is basically a chronic sleep disorder that can be characterized by overwhelming daytime sleepiness and sudden sleep attacks. People with narcolepsy often find it very difficult to stay awake for a very long period of time, regardless of the circumstances. Narcolepsy can seriously disturb your daily routine. Excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hallucinations, fragmented sleep, and insomnia, and automatic behaviors are observed symptoms. Sometimes narcolepsy can also be accompanied by a sudden loss of muscle tone (cataplexy) that can be triggered by various strong emotions. Narcolepsy, which occurs with cataplexy, is known as type 1 narcolepsy. Narcolepsy that occurs without cataplexy is hereby known as type 2 narcolepsy. Narcolepsy is basically a chronic condition for which there can be no cure. However, medications and lifestyle changes can help you relieve symptoms. There is presently no cure for narcolepsy, but medications, as well as a good lifestyle change, can help in relieving the symptoms. Medications that hereby stimulate the central nervous system are the main treatment so as to help people with narcolepsy staying awake during the day. Doctors most often try modafinil (Provigil) or armodafinil (Nuvigil) as the first treatments for narcolepsy. Modafinil and Armodafinil are not as addictive as older stimulants and do not produce the ups and downs often associated with older stimulants. Side effects are rare but can include headache, nausea, or anxiety.
The Narcolepsy Drug market study is being classified by Type (Antioxidants Type, Stimulants Type and Other), by Application (Daytime Extreme Sleepiness, Cataplexia and Others) and major geographies with country level break-up.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Narcolepsy Drug market throughout the predicted period.
Jazz Pharmaceuticals (Ireland), Teva Pharmaceutical Industries Ltd. (Israel), Novartis (Switzerland), Mylan (United States), Ligand Pharmaceuticals (United States), Addrenex Pharmaceuticals (United States), Shire Plc (United States), Arena Pharmaceuticals (United States), Bioprojet Pharma (France) and Graymark Healthcare, Inc. (United States) are some of the key players profiled in the study.
Analyst at AMA have segmented the market study of Global Narcolepsy Drug market by Type, Application and Region.
On the basis of geography, the market of Narcolepsy Drug has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Influencers and their development strategies
On 25th January 2019, Ligand Pharmaceuticals partnered with Seelos Therapeutics Inc., a leading biopharmaceutical company in the clinical trials stage, and it is officially now a public company. In 2016, Ligand had given rights to the four drugs that were manufactured by Seelos.
On June 11th, 2019, Addrenex Pharmaceuticals had received a license to manufacture drugs so as to treat Narcolepsy around the globe. The agreement with SK Holdings Co Ltd had helped the company to gain this license. According to Addrenex, the drug license would hereby provide quality treatment for excessive sleepiness, which thereby provided an amazing output in the clinical trials.
Influencing Market Trend
- Rise in Number of People Being Affected By Narcolepsy
- The Availability of Reimbursement Process for FDA-Approved Prescription Medicines
- Stressful Lifestyle and Increase in Consumption of Alcohol, Tobacco, and Coffee
- High Disposable Income
- Increase in Awareness about the Benefits of Narcolepsy Drugs
- Increase in the Number of Programs Organized By Various Organizations to Spread Awareness
- Increase in R&D Activities for the Development of These Type of Drugs by the Key Players
- Lack of Awareness Regarding the Diagnosis and Treatment
- Side Effects Associated With the Drugs
Key Target AudienceManufacturers of Narcolepsy Drug, Suppliers and Distributors of Narcolepsy Drug, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.